Merck KGaA
MKGAF
$145.36
-$2.55-1.72%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 22.88B | 22.73B | 22.57B | 22.58B | 22.70B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.88B | 22.73B | 22.57B | 22.58B | 22.70B |
| Cost of Revenue | 9.34B | 9.37B | 9.39B | 9.43B | 9.26B |
| Gross Profit | 13.55B | 13.37B | 13.19B | 13.15B | 13.45B |
| SG&A Expenses | 6.37B | 6.21B | 6.20B | 6.22B | 6.26B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 299.54M | 704.06M | 612.48M | 396.38M | 548.71M |
| Total Operating Expenses | 18.46B | 18.90B | 18.87B | 18.68B | 18.70B |
| Operating Income | 4.42B | 3.84B | 3.70B | 3.91B | 4.00B |
| Income Before Tax | 3.83B | 3.66B | 3.53B | 3.66B | 3.77B |
| Income Tax Expenses | 814.05M | 721.87M | 682.34M | 693.23M | 704.54M |
| Earnings from Continuing Operations | 3.02K | 2.94K | 2.85K | 2.97K | 3.07K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -9.77M | -8.73M | -7.61M | -13.02M | -11.89M |
| Net Income | 3.01B | 2.93B | 2.84B | 2.95B | 3.06B |
| EBIT | 4.42B | 3.84B | 3.70B | 3.91B | 4.00B |
| EBITDA | 6.28B | 5.69B | 5.54B | 5.74B | 5.84B |
| EPS Basic | 6.92 | 6.74 | 6.55 | 6.80 | 7.03 |
| Normalized Basic EPS | 6.31 | 5.56 | 5.38 | 5.55 | 5.71 |
| EPS Diluted | 6.92 | 6.73 | 6.54 | 6.80 | 7.02 |
| Normalized Diluted EPS | 6.31 | 5.56 | 5.38 | 5.55 | 5.71 |
| Average Basic Shares Outstanding | 1.74B | 1.74B | 1.74B | 1.74B | 1.74B |
| Average Diluted Shares Outstanding | 1.74B | 1.74B | 1.74B | 1.74B | 1.74B |
| Dividend Per Share | 2.35 | 2.37 | 2.37 | 2.37 | 2.37 |
| Payout Ratio | 36.88% | 37.89% | 39.03% | 41.03% | 41.00% |
